all AI news
GEDi Cube and Renovaro Biosciences ink agreement to combine
AI – AI-TechPark ai-techpark.com
Combined company aims to accelerate precision, personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better targeted treatments and drug discovery -AI technology products projected to be in marketplace in 2024 -Phase 1/2 human studies of pancreatic cancer and other solid tumors with poor...
The post GEDi Cube and Renovaro Biosciences ink agreement to combine first appeared on AI-TechPark.
ai ai technology biotechnology cancer diagnosis discovery drug discovery human longevity marketplace medicine personalized platforms precision products solid studies technology